BIOINDUSTRY · R&D SERVICES

Strain identification and cell banking

A production strain is an asset only if you know exactly what it is and can start again from the same cell ten years from now. Molecular identification and cell banking are the work that turns a culture into a documented, repeatable production line.

Talk to us about your strain
WHERE IT STARTS

Three situations that lead here

Identification and banking almost always come from one of these three needs, and which one it is decides the level of resolution required.

You are not certain what strain you have

An inherited culture, a collection isolate, a strain that arrived with an acquisition. Molecular identification and sequencing say what it actually is, at the resolution you need.

Every production starts from a different cell

Without a cell bank, batch-to-batch variability is structural. A Master and a Working Cell Bank fix the starting point and make it the same every time.

You have to demonstrate identity and purity

To a customer, a partner or an authority. Sequencing, comparative analysis and contaminant control, with the data in the form the file requires.

How a project runs

Three stages, each ending in a decision rather than a report. How long each takes depends on the organism and on what you have to be able to prove — we size it after the first conversation, not before.

Stage one

Identification and characterisation

Molecular identification of the strain, sequencing, up to the whole genome where needed where it is needed, and comparison against the relevant references. The output is what it is, with what degree of certainty, and what distinguishes it.

Stage two

Building the banks

Master Cell Bank and Working Cell Bank, cryopreservation at −80 °C, and on every bank produced the checks for identity, viability and absence of contaminants.

Stage three

Qualification and monitoring

Stability of the bank over time, later lots compared against the reference, and the molecular methods — qPCR and PMA-qPCR — that separate viable cells from residual DNA.

Bacteria, yeasts and filamentous fungi

16S rRNA for bacteria, ITS for yeasts and fungi, up to the whole genome where needed. Alongside, morphological identification in culture and counts by microbial group.

When a process gives anomalous results

We compare regular batches with anomalous ones, isolate and identify the microorganisms associated with the defect, and test in the laboratory whether they cause it.

What we measure

A strain is documented to the extent that the checks behind it are. These are the endpoints we report.

  • Strain identity — with the method and the level of resolution declared
  • Sequence — from a marker to the whole genome, according to what the project has to demonstrate
  • Viability — a viable count on every bank, measured rather than estimated
  • Purity and contaminants — verified on differential media and by qPCR
  • Viable versus non-viable — PMA-qPCR where counting DNA is not enough
  • Bank stability — identity and performance held over the storage period
  • Lot comparison — every new bank compared against the reference
  • Traceability — origin, passages and conditions documented for each bank

The laboratory behind it

Equipment

Molecular biologyExtraction, PCR, qPCR and PMA-qPCR, sequencing, up to the whole genome where needed
StorageCryopreservation and storage at −80 °C, with checks on every bank produced
MicrobiologyViable counts, differential and selective media, contaminant control

What you take away

BanksMCB and WCB, with the checks performed on each
DossierIdentity, sequences, checks and conditions, in the form your technical file needs
AliquotsSupplied in the quantities and on the timing production requires

Start with the strain

Tell us where the strain comes from and what you have to be able to prove. We will tell you what level of identification is needed and what the first stage would look like.

Talk to us about your strain

Tell us about your project

Write to us here: the division team will get back to you.